These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34456255)

  • 21. Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy.
    Adler B; Christopher-Stine L; Tiniakou E
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.
    Torri F; Ali G; Chico L; Siciliano G; Ricci G
    Acta Myol; 2021 Jun; 40(2):105-108. PubMed ID: 34355128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efgartigimod restores muscle function in a humanized mouse model of immune-mediated necrotizing myopathy.
    Julien S; van der Woning B; De Ceuninck L; Briand E; Jaworski T; Roussel G; Zoubaïri R; Allenbach Y; Benveniste O; Drouot L; Boyer O
    Rheumatology (Oxford); 2023 Dec; 62(12):4006-4011. PubMed ID: 37335864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.
    Prieto-Peña D; Ocejo-Vinyals JG; Mazariegos-Cano J; Pelayo-Negro AL; Remuzgo-Martínez S; Genre F; García-Dorta A; Renuncio-García M; Martínez-Taboada VM; García-Ibarbia C; Sánchez-Martín J; López-Hoyos M; Blanco R; González-Gay MA; Hernández JL
    Eur J Intern Med; 2022 Jul; 101():86-92. PubMed ID: 35487805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
    Khan F; Brady S; Kuttikat A
    Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O
    Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two cases of statin-induced immune-mediated necrotizing myopathy].
    Safi T; Wagner H
    Lakartidningen; 2021 Dec; 118():. PubMed ID: 34861042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic challenges and cardiovascular risk in patients with HMGCR-associated immune-mediated necrotizing myopathy (HMGR-IMNM) secondary to statins.
    Álvarez-Troncoso J; Molina SC; Robles-Marhuenda Á; Martínez-Robles E; Ríos-Blanco JJ
    Eur J Intern Med; 2023 Aug; 114():143-145. PubMed ID: 37179139
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.
    Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T
    Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune-Mediated Necrotizing Myopathy].
    Uruha A
    Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of immune-mediated necrotizing myopathy.
    Suh J; Amato AA
    Muscle Nerve; 2024 Aug; 70(2):166-172. PubMed ID: 38801022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.
    Yang H; Sun C; Ye L; Xu Y; Lin S; Peng Q; Wang G; Lu X
    Arthritis Res Ther; 2024 Sep; 26(1):158. PubMed ID: 39261921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease.
    Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M
    Front Immunol; 2022; 13():866701. PubMed ID: 35603214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review.
    Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P
    Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HMGCR myopathy: barriers to prompt recognition.
    Barp A; Merve A; Shah S; Desikan M; Hanna MG; Bugiardini E
    Pract Neurol; 2023 Jun; 23(3):239-242. PubMed ID: 36564213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.